前收市價 | 0.0500 |
開市 | 無 |
買盤 | 0.0000 |
賣出價 | 0.0000 |
拍板 | 22.00 |
到期日 | 2024-07-19 |
今日波幅 | 0.0500 - 0.0500 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 無 |
While blue chip stocks are always a good investment portfolio idea, I suggest some smart diversification. And one of the best ways that I know to diversify is to buy highly rated stocks under $10. Stocks under $10 may not sound interesting, but these names can be a strategic move for anyone wanting to diversify and improve their portfolios. While cautious investors will associate lower-priced stocks with higher risk, the Portfolio Grader can help you find some outstanding choices to round out a
These high-flying stocks could have more room to run if analysts are right.
Summit Therapeutics (SMMT) surges after data from a late-stage study shows that its experimental antibody beat Merck's Keytruda in a head-to-head setting in treating certain patients with lung cancer.